Study: Nail-Biters, Thumb-Suckers Have Fewer Allergies

The findings of a longitudinal study in New Zealand lend support to the hygiene hypothesis.

Written byTanya Lewis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIAAs kids, we’re often told not to suck our thumbs or bite our nails, but there may be an unappreciated benefit to these “dirty” habits: fewer allergies, scientists suggest. Through a longitudinal study that followed 1,037 children born in Dunedin, New Zealand, between 1972 and 1973 to adulthood, researchers from the University of Otago, New Zealand, and their colleagues found that kids who engaged in one of these habits had a 39 percent risk of testing positive to at least one common allergen at age 13, compared with 49 percent of kids who did not bite their nails or suck their thumbs. Kids who were both nail-biters and thumb-suckers had only a 31 percent risk, the researchers reported online today (July 11) in Pediatrics.

“The findings support the ‘hygiene hypothesis,’ which suggests that being exposed to microbes as a child reduces your risk of developing allergies,” study coauthor Robert Hancox, a professor of respiratory epidemiology at the University of Otago, said in a statement.

Parents of the study participants reported whether their children engaged in thumb-sucking or nail-biting when their kids were 5, 7, 9, and 11 years old. At ages 13 and 32, the participants underwent atopic sensitization (skin prick) tests. The lower rates of sensitization among thumb-suckers and nail-biters at age 13 persisted into adulthood, even after adjusting for factors such as family history, sex, pet ownership, and breastfeeding. The researchers found no difference among the participants in their risk of developing asthma or hay fever, however.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies